ALKBH5 and neoplasm: In contrast, compared to normal HSPCs or other types of stem cells, Shen et al. [65] revealed that ALKBH5 deficiency significantly inhibits tumor proliferation in many types of tumors, such as breast cancer, brain tumors, and acute myeloid leukemia (AML).